In consideration of the dual roles of GLP-1RAs in hypoglycemic effects and preventing CVD among T2DM patients, we reviewed the cardiovascular effects and molecular mechanisms of GLP-1RAs in CVOTs, animal models and cultured cells, and discuss how these findings transform pharmacotherapies for T2DM, and even expand the indication of this important category of anti-diabetic drugs to CVD patients without diabetes
Amy Curtis From X-Rays to Ray-zing the Roof This doctor is there for Spartanburg
Negotiations for the second cycle of the Inflation Reduction Acts drug pricing program have wrapped up, and the Centers for Medicare and Medicaid Services on Tuesday released the final agreed-upon prices for the 15 covered medicines
This includes your comprehensive clinical support, high-quality compounded vials, and all necessary medical supplies
[1] [2] As an investigational medicinal product (IMP), it does not yet hold a marketing authorisation from the MHRA or EMA, and no product-specific storage data are publicly available